Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Scottish National Blood Transfusion Service directors and haemophilia centre directors discussed the effectiveness of the AIDS leaflet. It was felt that "some modifications might be made" and emphasised that the leaflet must, in the absence of a screening test, be given to all prospective donors.

  • Read more about Scottish National Blood Transfusion Service directors and haemophilia centre directors discussed the effectiveness of the AIDS leaflet. It was felt that "some modifications might be made" and emphasised that the leaflet must, in the absence of a screening test, be given to all prospective donors.

In a meeting of directors of the Scottish National Blood Transfusion Service, Dr John Cash recommended reducing the number of batch exposures per patient per year.

  • Read more about In a meeting of directors of the Scottish National Blood Transfusion Service, Dr John Cash recommended reducing the number of batch exposures per patient per year.

In a meeting of the Haemophilia and Blood Transfusion Working Group, Dr Cash raised concerns about the amount of commercial product being used.

  • Read more about In a meeting of the Haemophilia and Blood Transfusion Working Group, Dr Cash raised concerns about the amount of commercial product being used.

At a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia directors, Dr Cash "emphasised the important part cryoprecipitate could play in haemophilia treatment" and urged for "serious consideration of the use of cryoprecipitate for" home treatment. Haemophilia directors were reported as "generally not in favour of using cryoprecipitate in this way".

  • Read more about At a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia directors, Dr Cash "emphasised the important part cryoprecipitate could play in haemophilia treatment" and urged for "serious consideration of the use of cryoprecipitate for" home treatment. Haemophilia directors were reported as "generally not in favour of using cryoprecipitate in this way".

Dr John Cash published an article in The British Medical Journal entitled "Haemophilia A and the blood transfusion service: a Scottish study". The article stated that cryoprecipitate was suitable for home treatment.

  • Read more about Dr John Cash published an article in The British Medical Journal entitled "Haemophilia A and the blood transfusion service: a Scottish study". The article stated that cryoprecipitate was suitable for home treatment.

Regional transfusion directors were asked to increase their production of cryoprecipitate as a much lower risk product.

  • Read more about Regional transfusion directors were asked to increase their production of cryoprecipitate as a much lower risk product.

Donor eligibility was established by a qualified clerk asking pre-prepared questions in the presence of a medical officer.

  • Read more about Donor eligibility was established by a qualified clerk asking pre-prepared questions in the presence of a medical officer.

In a letter to colleagues, Dr Charles Bowley sought to make a case for using better quality cryoprecipitate instead of imported factor concentrates.

  • Read more about In a letter to colleagues, Dr Charles Bowley sought to make a case for using better quality cryoprecipitate instead of imported factor concentrates.

Regional transfusion centres kept the records of donors who tested positive for HIV and hepatitis separately from their other records, to ensure their confidentiality.

  • Read more about Regional transfusion centres kept the records of donors who tested positive for HIV and hepatitis separately from their other records, to ensure their confidentiality.

Professor Stanislaw Urbaniak set up a Hospital Transfusion Committee in the Aberdeen Royal Infirmary to monitor usage and compliance with maximum surgical blood ordering schedules for each operation and procedure that might require a transfusion.

  • Read more about Professor Stanislaw Urbaniak set up a Hospital Transfusion Committee in the Aberdeen Royal Infirmary to monitor usage and compliance with maximum surgical blood ordering schedules for each operation and procedure that might require a transfusion.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 645
  • Page 646
  • Page 647
  • Page 648
  • Current page 649
  • Page 650
  • Page 651
  • Page 652
  • Page 653
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.